Ark Delays Initial Public Offering Due To Unfavorable Conditions May 22, 2002 By Nuala Moran No Comments LONDON - Ark Therapeutics Group plc postponed its initial public offering on the London Stock Market, blaming "unusually adverse market conditions." (BioWorld International)Read More
CAT Releases Positive Follow-Up Results In Phase II CAT-152 Trial May 15, 2002 By Nuala Moran No Comments
CAT Releases Positive Follow-Up Results In Phase II CAT-152 Trial May 15, 2002 By Nuala Moran No Comments
